[1]马秀才 熊蠡茗 傅德皓 林松 邵增务△.华蟾素诱导骨肉瘤细胞凋亡及其机制[J].中国中医骨伤科杂志,2015,23(08):6-10.
　MA Xiucai XIONG Liming FU Dehao LIN Song SHAO Zengwu.Effect and Mechanism of Cinobufotalin Induces Apoptosis in Osteosarcoma Cells[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2015,23(08):6-10.
点击复制

华蟾素诱导骨肉瘤细胞凋亡及其机制
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第23卷
期数:
2015年08期
页码:
6-10
栏目:
实验研究
出版日期:
2015-08-15

文章信息/Info

Title:
Effect and Mechanism of Cinobufotalin Induces Apoptosis in Osteosarcoma Cells
文章编号:
1005-0205(2015)08-0006-05
作者:
马秀才1 熊蠡茗1 傅德皓1 林松1 邵增务1△
1.华中科技大学同济医学院附属协和医院骨科(武汉,430022)
△.通信作者 E-mail:szwjj@medmail.com.cn
Author(s):
MA Xiucai1 XIONG Liming1 FU Dehao1 LIN Song1 SHAO Zengwu1△
1.Department of Orthopedics,Union Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China
关键词:
华蟾素;  骨肉瘤细胞;  细胞凋亡;  Bax;  Bcl-2
Keywords:
cinobufotalin;  human osteosarcoma cells;  cell apoptosis;  Bax;  Bcl-2
分类号:
R-33
文献标志码:
A
摘要:
目的:探讨华蟾素诱导骨肉瘤U2OS细胞凋亡的效果及其可能机制。方法:体外培养人骨肉瘤细胞系U2OS,将其分为第1,2,3,4,5组,于其培养基内分别加入0,0.5,1.0,1.5,2.0 μg/mL华蟾素,每组分别于培养的第24,48,72 h进行检测。MTT法检测各组骨肉瘤细胞生长的抑制率,TUNEL染色观察第4组细胞凋亡程度并计算其凋亡率,免疫荧光染色检测第4组凋亡相关蛋白Bax和Bcl-2的含量并计算其比值,RT-PCR检测Bax和Bcl-2的表达。结果:MTT试验显示,随着各组华蟾素浓度的增加,细胞生长抑制率明显增加,其中第5组48 h生长抑制率增加至(59.56±1.95)%,相当于第2组同期(22.85±1.34)%的2.5倍(P<0.01)。随着培养时间的延长,各组细胞生长抑制均有不同程度的增加,以第5组72 h最为显著。Tunel染色显示,随着华蟾素干预时间的延长,U20S细胞凋亡率显著上升,与华蟾素作用于细胞24,48时相比,作用72 h后凋亡率达到(32.35±1.57)%,凋亡率明显增加(P<0.01)。免疫荧光和RT-PCR提示,随着华蟾素作用时间的延长,第4组Bax的表达逐渐增加,而Bcl-2的表达逐渐减少,同时Bax/Bcl-2含量的比值也逐渐增加。结论:华蟾素具有抑制骨肉瘤U2OS细胞增殖和诱导其凋亡的作用,其疗效呈剂量和时间依赖性,而其机制可能与华蟾素影响Bax和Bcl-2的表达有关。华蟾素具有治疗骨肉瘤的潜力,值得进一步研究探讨。
Abstract:
Objective:To investigate the effect and mechanism of cinobufotalin induced apoptosis in osteosarcoma cell line U2OS.Methods:Human osteosarcoma cell line U2OS were cultured in vitro and divided into 1st,2nd,3rd,4th,and 5th group.Then,different concentration of cinobufotalin(0,0.5,1.0,1.5,and 2.0 μg /mL)were added to their respective medium.The 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide(MTT)assay was used to evaluate the inhibition rate of osteosarcoma cell growth.The TUNEL staining methods was used to detect the change in cell morphology of apoptosis in the 4th group,and the apoptosis rate was calculated.The immunofluorescence and reverse transcription-polymerase chain reaction(RT-PCR)were used to detect the expression of apoptosis-related proteins,and then the Bax/Bcl-2 ratio was calculated.Results:The MTT assay showed that with the increasing of the concentration of cinobufotalin,the inhibition of cell growth was significantly increased.The growth inhibition rate of 4th group was increased to(59.56±1.95)%,equivalent to 2.5 times of 1st group(22.85±1.34)% 48 h after treated with cinobufotalin(P<0.01).With the extension of incubation time,the cell growth of each group was all inhibited,especially in the 4th group 72 h after treatment.Tunel staining showed that with the extension of incubation time,the U2OS cell apoptosis rate was significantly increased.The cell apoptosis rate was significantly increased to(32.35±1.57)% at 72 h,which was significantly higher than that at 24 h and 28 h after treated with cinobufotalin(P<0.01).The results of immunofluorescence and RT-PCR showed that with the extension time of incubation with cinobufotalin in the 4th group,the expression of Bax was increased,while Bcl-2 was decreased,moreover,the ratio of Bax/Bcl-2 was also increased.Conclusion:Cinobufotalin can induce apoptosis in U2OS cells,and its affects are in a dose-and time-dependent manner.The possible mechanisms are related to the expression of Bax and Bcl-2.Cinobufotalin is potentially effective to treat osteosarcoma,so it is worthy for further investigation.

参考文献/References:

[1] Qi F,Li A,Zhao L,et al.Cinobufacini,an aqueous extract from bufo gargarizans cantor,induces apoptosis through a mitochondria-mediated pathway in human hepatocellular carcinoma cells[J].J Ethnopharmacol,2010,128:654-661.
[2] Li J,Ma X,Li F,et al.Preparative separation and purification of bufadienolides from Chinese traditionnal medicine of Chansu using high-speed counter-current chromatography[J].J Sep Sci,2010,33(9):1325-1330.
[3] Ma L,Song B,Jin H,et al.Cinobufacini induced MDA-MB-231 cell apoptosis-associated cell cycle arrest and cytoskeleton function[J].Bioorg Med Chem Lett,2012,22:1459-1463.
[4] Qi J,Tan CK,Hashimi SM,et al.Toad glandular secretions and skin extrac tions as anti-inflammatory and anticancer agents[J].Evid Based Complement Alterna Med,2014:312684.
[5] Lu J,Deng S,Chen H,et al.Microbial transformation of cinobufotalin by Al ternaria alternate AS 3.457 8 and Aspergillus niger AS 3.739[J].J Mol Catal B:Enzymatic,2013,89:102-107.
[6] Emam H,Zhao QL,Furusawa Y,et al.Apoptotic cell death by the novel natural compound,cinobufotalin[J].Chem-Biol Interact,2012,199(3):154-160.
[7] Qi F,Li A,Inagaki Y,et al.Induction of apoptosis by cinobufacini preparation through mitoch-ondria and Fas-mediated caspase-dependent pathways in human hepatocellular carcinoma cells[J].Food Chem Toxicol,2012,50(2):295-302.
[8] Zuo XD,Cui YA,Qin SK,et al.Clinical research progress on the antitumor effects of cinobufacini[J].Chinese Clinical Oncology,2003,8:232-235.
[9] Inagaki Y,Tang W,Zhang L,et al.Novel aminopep-tidase N(APN/CD13)inhibitor 24F can suppress invasion of hepatocellular carcinoma cells as well as angiogenesis[J].Biosci Trends,2010,4(2):56-60.
[10] 周忠,王和鸣.八宝丹诱导骨肉瘤细胞U2OS凋亡及其机制的研究[J].中国中医骨伤科杂志,2007,15(5):32-34.
[11] 周尧,张俐.抑制骨肉瘤Survivin表达的中药研究概况[J].中国中医骨伤科杂志,2013,21(2):65-57.
[12] Huang T,Gong WH,Li X,et al.Efficient killing effect of osteosarcoma cells by cinobufacini and cisplatin in combination[J].Asian Pac J Cancer Prev,2012,13(5):2847-2851.
[13] Xie X,Huang X,Li J,et al.Efficacy and safety of Huachansu combined with chemotherapy in advanced gastric cancer:a meta-analysis[J].Med Hypotheses,2013,81(2):243-250.
[14] Zhai XF,Chen Z,Li B,et al.Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma:a multicenter rando-mized contro-lled trial[J].J Integr Med,2013,11(2):90-100.
[15] Kushnir I,Kolander Y,Bickels J,et al.Is it important to maintain high-dose intensity chemotherapy in the trea-tment of adults with osteosarcoma?[J].Med Oncol,2014,31(5):936.
[16] Takai N,Ueda T,Nishida M,et al.Bufalin induces growth inhibition,cell cycle arrest and apoptosis in human endometrial and ovarian can-cer cells[J].Int J Mol Med,2012,21(5):637-643.
[17] Wang L,Raju U,Milas L,et al.Huachansu containing cardiac glycosides enhances radiosensitivity of human lung cancer cells[J].Anticancer Res,2011,31(6):2141-2148.
[18] Wang D,Bi Z.Bufalin inhibited the growth of human osteosarcoma MG-63 cells via down-regulation of Bcl-2/Bax and triggering of the mitochondrial pathway[J].Tumor Biol,2014,35(5):4885-4890.
[19] Yin J,Wen L,Wu L,et al.The glycogen synthase kinase-3/nuclear factor-kappa B pathway is involved in cinobufagin-induced apoptosis in cultured osteosarcoma cells[J].Toxicol Lett,2013,218(2):129-136.
[20] Cai Y,Mohseny AB,Karperien M,et al.Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma[J].J Pathol,2010,220(1):24-33.
[21] Guo Y,Zi X,Koontz Z,et al.Blocking Wnt/LRP5 signaling by a soluble receptor modulates the epithelial to mesenchymal transition and suppresses met and metalloproteinases in osteosarcoma Saos-2 cells[J].J Orthop Res,2007,25(7):964-971.

备注/Memo

备注/Memo:
收稿日期:2015-02-02
更新日期/Last Update: 2015-08-15